tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastiski līdzekļi - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.
retsevmo
eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastiski līdzekļi - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.
emtricitabine/tenofovir disoproxil sandoz 200 mg/245 mg apvalkotās tabletes
sandoz d.d., slovenia - emtricitabinum, tenofovirum disoproxilum - apvalkotā tablete - 200 mg/245 mg
isentress
merck sharp & dohme b.v. - raltegravīrs - hiv infekcijas - pretvīrusu līdzekļi sistēmiskai lietošanai - isentress ir norādītas kopā ar citiem antiretrovirālo zāļu, lai ārstētu cilvēku imūndeficīta vīrusu (hiv 1) infekcija.
emtricitabine/tenofovir disoproxil teva 200 mg/245 mg apvalkotās tabletes
teva b.v., netherlands - emtricitabinum, tenofovirum disoproxilum - apvalkotā tablete - 200 mg/245 mg
atorvastatin beximco 10 mg apvalkotās tabletes
beximco pharma uk ltd., united kingdom - atorvastatīns - apvalkotās tabletes - 10 mg
atorvastatin beximco 20 mg apvalkotās tabletes
beximco pharma uk ltd., united kingdom - atorvastatīns - apvalkotās tabletes - 20 mg
rosuchen 20 mg apvalkotās tabletes
antibiotice s.a., romania - rosuvastatīns - apvalkotā tablete - 20 mg
rosuchen 40 mg apvalkotās tabletes
antibiotice s.a., romania - rosuvastatīns - apvalkotā tablete - 40 mg
tulip 20 mg apvalkotās tabletes
sandoz d.d., slovenia - atorvastatīns - apvalkotā tablete - 20 mg